Hamdan Abdul-Latif, Hosri Jad, El Hadi Nadine, Abou Chaar Jonathan, Semaan Zeina, Kodeih Sacha, Korban Zeina
Department of Otolaryngology-Head and Neck Surgery, Rhinology and Endoscopic Skull Base Surgery, American University of Beirut Medical Center, 11-0236, Riad El Solh, Beirut, 1107 2020, Lebanon.
Faculty of Medicine & Medical Sciences, University of Balamand, Koura, Lebanon.
Eur Arch Otorhinolaryngol. 2025 Feb;282(2):821-825. doi: 10.1007/s00405-024-09078-x. Epub 2024 Dec 23.
To investigate the risk of swallowing disorders and the frequency and intensity of vocal tract symptoms in patients with chronic rhinosinusitis and nasal polyposis (CRSwNP).
Adult patients diagnosed with CRSwNP presenting to the rhinology clinic of a tertiary referral center between March 2023 and March 2024, were recruited. Patients with acute or recent history of respiratory tract infections, tonsillitis, pharyngitis or otitis, were excluded. The frequency and severity of nasal symptoms and their impact on quality of life was assessed using the Sinonasal Outcome Test (SNOT-22). The Eating Assessment Tool (EAT-10) was used to evaluate the risk of swallowing disorders, and the Vocal Tract Discomfort Scale (VTDS) was used to evaluate the frequency and intensity of vocal tract symptoms.
Twenty-five patients with CRSwNP and 25 controls were recruited for this study. There was a statistically significant difference in the mean EAT-10 score between the study group and control group (3.52 ± 4.68 vs.0.88 ± 1.83; p = 0.013). There was also a statistically significant difference in the mean VTDS score between the study group and control group (12.56 ± 7.9 vs. 4 ± 4.64; p < 0.001). There was a positive moderate correlation between the VTDS score and the SNOT-22 score (r = 0.595; p < 0.001).
The study indicates that patients with CRSwNP have a higher risk for swallowing disorders and are more likely to experience vocal tract symptoms than healthy controls.
探讨慢性鼻-鼻窦炎伴鼻息肉(CRSwNP)患者吞咽障碍的风险以及声道症状的频率和严重程度。
招募2023年3月至2024年3月期间到三级转诊中心鼻科门诊就诊、被诊断为CRSwNP的成年患者。排除有急性或近期呼吸道感染、扁桃体炎、咽炎或中耳炎病史的患者。使用鼻窦结局测试(SNOT-22)评估鼻部症状的频率和严重程度及其对生活质量的影响。使用饮食评估工具(EAT-10)评估吞咽障碍的风险,使用声道不适量表(VTDS)评估声道症状的频率和严重程度。
本研究招募了25例CRSwNP患者和25例对照。研究组和对照组的平均EAT-10评分存在统计学显著差异(3.52±4.68 vs.0.88±1.83;p = 0.013)。研究组和对照组的平均VTDS评分也存在统计学显著差异(12.56±7.9 vs. 4±4.64;p < 0.001)。VTDS评分与SNOT-22评分之间存在中度正相关(r = 0.595;p < 0.001)。
该研究表明,CRSwNP患者比健康对照有更高的吞咽障碍风险,并且更有可能出现声道症状。